Leuko is a Non-Invasive White Blood Cell Monitoring founded in 2017.
2
Funding Rounds
$6.8m
Money raised
Access comprehensive data and insights available only to Seedtable members
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
The company Leuko has raised a total of $5m in funding over 2 rounds.